PALM HARBOR, Fla., Sept. 24, 2014 \/PRNewswire\/ --The Palo Alto Longevity Prize is a $1 million life science competition that challenges teams from all over the world to extend life spans. For more information log on to http:\/\/www.PaloAltoPrize.com<\/a>. Regenerative Processing Plant, LLC (RPP) has accepted this ambitious challenge and has registered their intent to participate. <\/p>\n In a recent study, Harvard scientists found a protein that could reverse the aging process; May 2014, the Harvard Stem Cell Institute showed injections of a growth factor called Growth Differentiation Factor 11 (GDF-11) appears to have special regenerative properties. Many tissues, including damaged muscle, were shown to regenerate in the study. Thus, GDF-11 is being called the \"Youth Hormone\". <\/p>\n Regenerative Processing Plant's (RPP) First Sterile Product: PDA Human Amniotic Fluid is also the first product on the market to Lot test for the presence of GDF-11. <\/p>\n Dr. C. Randall Harrell, RPP'S CEO and Medical Director comments that: <\/p>\n \"GDF-11 is an exciting discovery for Regenerative Medicine. We are proud to have the first Amniotic Fluid product on the market to recognize the regenerative healing potential of GDF-11.\" <\/p>\n He expressed enthusiasm about the upcoming product launch, stating: <\/p>\n \"RPP was established to help bring the science of the body's natural ability to heal itself to the practice of medicine using safe and effective products. RPP intensely focuses on the science of regenerative healing with a world class team of scientists.\" <\/p>\n RPP's products are available to the healthcare community now for the treatment of Plastic Surgery, Wound Healing, Sports Medicine, Pain Management, Orthopedics, Spinal Therapies and other Regenerative Medicine Therapies through their personal physician. Dr. Harrell also notes: <\/p>\n \"For years, professional athletes and wealthy individuals have traveled around the world seeking similar treatments to expedite repair and healing of injuries and degenerative diseases. Now everyone can have access to the same opportunities right here at home, collected and manufactured in the USA.\" <\/p>\n RPP has several additional products in R&D and will continue to focus on their Proprietary Patented PDA Sterile Process and placental derived amnion products. To learn more about RPP's products, please contact Raquel Roque, 800-781-0818. <\/p>\n <\/p>\n Continued here: PALM HARBOR, Fla., Sept. 24, 2014 \/PRNewswire\/ --The Palo Alto Longevity Prize is a $1 million life science competition that challenges teams from all over the world to extend life spans Continue reading
\n$1 million Palo Alto Longevity "Fountain of Youth" Prize - Regenerative Processing Plant Accepts the Challenge!<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"